{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:48:22Z","timestamp":1783439302872,"version":"3.54.6"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To evaluate the progression of brain glucose metabolism among participants with biological signature of Alzheimer\u2019s disease (AD) and its relevance to cognitive decline.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>We studied 602 amyloid positive individuals who underwent 18F-fluorodeoxyglucose PET (FDG-PET) scan, 18F-AV-45 amyloid PET (AV45-PET) scan, structural MRI scan and neuropsychological examination, including 116 cognitively normal (CN) participants, 314 participants diagnosed as mild cognitive impairment (MCI), and 172 participants diagnosed as AD dementia. The first FDG-PET scan satisfying the inclusion criteria was considered as the baseline scan. Cross-sectional analysis were conducted with the baseline FDG-PET data to compare the regional differences between diagnostic groups after adjusting confounding factors. Among these participants, 229 participants (55 CN, 139 MCI, and 35 AD dementia) had two-year follow-up FDG-PET data available. Regional glucose metabolism was computed and the progression rates of regional glucose metabolism were derived from longitudinal FDG-PET scans. Then the group differences of regional progression rates were examined to assess whether glucose metabolism deficit accelerates or becomes stable with disease progression. The association of cognitive decline rate with baseline regional glucose metabolism, and progression rate in longitudinal data, were evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Participants with AD dementia showed substantial glucose metabolism deficit than CN and MCI at left hippocampus, in addition to the traditionally reported frontal and parietal\u2013temporal lobe. More substantial metabolic change was observed with the contrast AD \u2013 MCI than the contrast MCI \u2013 CN, even after adjusting time duration since cognitive symptom onset. With the longitudinal data, glucose metabolism was observed to decline the most rapidly in the AD dementia group and at a slower rate in MCI. Lower regional glucose metabolism was correlated to faster cognitive decline rate with mild\u2013moderate correlations, and the progression rate was correlated to cognitive decline rate with moderate-large correlations.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion and conclusion<\/jats:title><jats:p>Hippocampus was identified to experience hypometabolism in AD pathology. Hypometabolism accelerates with disease progression toward AD dementia. FDG-PET, particularly longitudinal scans, could potentially help predict how fast cognition declines and assess the impact of treatment in interventional trials.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnins.2023.1151820","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T04:40:38Z","timestamp":1681447238000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Accelerated hypometabolism with disease progression associated with faster cognitive decline among amyloid positive patients"],"prefix":"10.3389","volume":"17","author":[{"given":"Zhengshi","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jefferson W.","family":"Kinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietmar","family":"Cordes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,14]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.1093\/brain\/awv278","article-title":"Regional brain hypometabolism is unrelated to regional amyloid plaque burden","volume":"138","author":"Altmann","year":"2015","journal-title":"Brain"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1001\/archneur.62.11.1728","article-title":"Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease","volume":"62","author":"Anchisi","year":"2005","journal-title":"Arch. Neurol."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.neurobiolaging.2018.01.002","article-title":"Hypermetabolism in the hippocampal formation of cognitively impaired patients indicates detrimental maladaptation","volume":"65","author":"Apostolova","year":"2018","journal-title":"Neurobiol. Aging"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2967\/jnumed.111.096578","article-title":"Effectiveness and safety of <sup>18<\/sup>F-FDG PET in the evaluation of dementia: A review of the recent literature","volume":"53","author":"Bohnen","year":"2012","journal-title":"J. Nucl. Med."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1212\/01.WNL.0000055847.17752.E6","article-title":"Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer\u2019s disease?","volume":"60","author":"Ch\u00e9telat","year":"2003","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0197-4580(01)00230-5","article-title":"Hippocampal formation glucose metabolism and volume losses in MCI and AD","volume":"22","author":"De Santi","year":"2001","journal-title":"Neurobiol. Aging"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1212\/01.wnl.0000244749.20056.d4","article-title":"Amyloid, hypometabolism, and cognition in Alzheimer disease: An [11C] PIB and [18F] FDG PET study","volume":"68","author":"Edison","year":"2007","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.neurobiolaging.2010.03.011","article-title":"Cognition, glucose metabolism and amyloid burden in Alzheimer's disease","volume":"33","author":"Furst","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"ref9","first-page":"49","article-title":"A critique of the 2018 National Institute on Aging\u2019s research framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"9","author":"Garrett","year":"2018","journal-title":"Curr. Neurobiol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10654-018-0418-4","article-title":"Will biomarker-based diagnosis of Alzheimer\u2019s disease maximize scientific progress? Evaluating proposed diagnostic criteria","volume":"33","author":"Glymour","year":"2018","journal-title":"Eur. J. Epidemiol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: The amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1006\/nimg.2002.1208","article-title":"Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET","volume":"17","author":"Herholz","year":"2002","journal-title":"NeuroImage"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/acn3.782","article-title":"Predicting long-term clinical stability in amyloid-positive subjects by FDG-PET","volume":"6","author":"Iaccarino","year":"2019","journal-title":"Ann. Clin. Trans. Neurol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"National Institute on Aging\u2014Alzheimer\u2019s association (NIA-AA) research framework. NIA-AA research framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimers Dement."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e2282","DOI":"10.1212\/WNL.0000000000200287","article-title":"Characterizing amyloid-positive individuals with normal tau PET levels after 5 years: An ADNI study","volume":"98","author":"Josephs","year":"2022","journal-title":"Neurology"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1002\/ana.23650","article-title":"Amyloid deposition, hypometabolism, and longitudinal cognitive decline","volume":"72","author":"Landau","year":"2012","journal-title":"Ann. Neurol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1212\/WNL.0000000000000467","article-title":"Association of hypometabolism and amyloid levels in aging, normal subjects","volume":"82","author":"Lowe","year":"2014","journal-title":"Neurology"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00401-018-1918-8","article-title":"Questions concerning the role of amyloid-\u03b2 in the definition, aetiology and diagnosis of Alzheimer\u2019s disease","volume":"136","author":"Morris","year":"2018","journal-title":"Acta Neuropathol."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.neurobiolaging.2006.12.008","article-title":"Hippocampal hypometabolism predicts cognitive decline from normal aging","volume":"29","author":"Mosconi","year":"","journal-title":"Neurobiol. Aging"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00259-008-1039-z","article-title":"FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer\u2019s disease","volume":"36","author":"Mosconi","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1212\/01.WNL.0000147469.18313.3B","article-title":"MCI conversion to dementia and the APOE genotype: A prediction study with FDG-PET","volume":"63","author":"Mosconi","year":"2004","journal-title":"Neurology"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"390","DOI":"10.2967\/jnumed.107.045385","article-title":"Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias","volume":"49","author":"Mosconi","year":"","journal-title":"J. Nucl. Med."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13195-019-0512-1","article-title":"FDG-PET as an independent biomarker for Alzheimer\u2019s biological diagnosis: A longitudinal study","volume":"11","author":"Ou","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejrad.2017.07.014","article-title":"The diagnostic value of FDG and amyloid PET in Alzheimer\u2019s disease\u2014A systematic review","volume":"94","author":"Rice","year":"2017","journal-title":"Eur. J. Radiol."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroimage.2015.07.075","article-title":"Implementation of a new parcellation of the orbitofrontal cortex in the automated anatomical labeling atlas","volume":"122","author":"Rolls","year":"2015","journal-title":"NeuroImage"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/hipo.20573","article-title":"Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer's disease: Meta-analyses of MRI studies","volume":"19","author":"Shi","year":"2009","journal-title":"Wiley Online Library"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.neuron.2014.10.038","article-title":"The evolution of preclinical Alzheimer\u2019s disease: Implications for prevention trials","volume":"84","author":"Sperling","year":"2014","journal-title":"Neuron"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1093\/brain\/awab294","article-title":"Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer\u2019s disease","volume":"145","author":"Strom","year":"2021","journal-title":"Brain"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: A prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3174\/ajnr.A1357","article-title":"Fluorodeoxyglucose\u2013positron-emission tomography, single-photon emission tomography, and structural MR imaging for prediction of rapid conversion to Alzheimer disease in patients with mild cognitive impairment: A meta-analysis","volume":"30","author":"Yuan","year":"2009","journal-title":"Am. J. Neuroradiol."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1151820\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T04:40:41Z","timestamp":1681447241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2023.1151820\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,14]]},"references-count":32,"alternative-id":["10.3389\/fnins.2023.1151820"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2023.1151820","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,14]]},"article-number":"1151820"}}